EW Filing
4Filing Date: Jun 30, 2026

Edwards Lifesciences Corp (EW) · Insider Trading (Form 4) SEC Filing

Statement of Changes in Beneficial Ownership

descriptionView SEC Filing
ACC: 0001225208-26-006263open_in_new
Total Value$101.6K
Trades3
Insiders1

Transaction Details

Lippis Daniel J.
CVP, TAVR·Direct
Sell · Dispose
Common Stock
Shares-619
Price$91.40
Total Value$56.6K
Shares Owned After40.41K
Transaction DateJun 30, 2026
10b5-1
Footnotes ▸

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026. | This transaction was executed in multiple trades at prices ranging from $91.185 to $91.650. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Lippis Daniel J.
CVP, TAVR·Direct
Exercise · Dispose
Employee Stock Option (Right to Acquire)Derivative
Shares-619
Price$0.00
Total Value$0
Shares Owned After5.57K
Transaction DateJun 30, 2026
ExpiresMay 6, 2027
10b5-1
Lippis Daniel J.
CVP, TAVR·Direct
Exercise · Acquire
Common Stock
Shares+619
Price$72.68
Total Value$45.0K
Shares Owned After41.03K
Transaction DateJun 30, 2026
10b5-1
Footnotes ▸

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026.

Post-Transaction Holdings

Lippis Daniel J.
SecuritySharesChange
Common Stock40.41K-
Employee Stock Option (Right to Acquire)5.57K-619 (-10.00%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-06-30 10b5-1 Pre-arranged Plan: Yes --- Issuer --- Name: Edwards Lifesciences Corp (EW) CIK: 0001099800 --- Reporting Owner --- Name: Lippis Daniel J. CIK: 0002004380 Role: Officer (CVP, TAVR) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-06-30 | Code: M (Exercise of derivative) Shares: +619 | Price: $72.68 Total Value: $44,988.92 Shares Owned After: 41,029.9103 | Ownership: D (Direct) Footnotes: [F1] The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026. [Transaction #2] Security: Common Stock Date: 2026-06-30 | Code: S (Open market sale) Shares: -619 | Price: $91.40 Total Value: $56,576.72 Shares Owned After: 40,410.9103 | Ownership: D (Direct) Footnotes: [F1] The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026. [F2] This transaction was executed in multiple trades at prices ranging from $91.185 to $91.650. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. --- Derivative Transactions --- [Transaction #1] Security: Employee Stock Option (Right to Acquire) Date: 2026-06-30 | Code: M (Exercise of derivative) Shares: -619 | Price: $0.00 Exercisable: N/A | Expires: 2027-05-06 Shares Owned After: 5,571 | Ownership: D (Direct) --- Footnotes (Complete Index) --- F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026. F2: This transaction was executed in multiple trades at prices ranging from $91.185 to $91.650. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. --- Signature --- /s/ Linda J. Park, Attorney-in-Fact (2026-06-30)

keid AI analysis is for reference only and does not constitute investment advice.